Telomerase in hepatocellular carcinoma, metastatic carcinoma and chronic liver disease

被引：0
|
作者：
Li, HM [1 ]
Wu, S [1 ]
Liew, CT [1 ]
Loew, CK [1 ]
Lau, JWY [1 ]
Lim, BK [1 ]
Wang, XQ [1 ]
Chan, JYH [1 ]
Lee, JCK [1 ]
机构：
[1] CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT ANAT & CELLULAR PATHOL SURG CLIN ONCOL,SHATIN,HONG KONG
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1307 / 1307
页数：1
相关论文
共 50 条
  • [41] Economic outcomes in hepatocellular carcinoma and metastatic liver disease patients: A Medicare perspective
    Pelletier, EM
    Dembek, CJ
    Gazelle, GS
    VALUE IN HEALTH, 2006, 9 (03) : A108 - A109
  • [42] Physician Awareness of Hepatocellular Carcinoma Surveillance in Patients With Chronic Liver Disease
    Ofori, Emmanuel
    Ramai, Daryl
    Ofosu, Andrew
    Etienne, Denzil
    Lin, Kyawzaw
    Dhawan, Monica
    Reddy, Madhavi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S555 - S555
  • [43] Insulin Resistance and Hyperinsulinemia in Patients with Chronic Liver Disease and Hepatocellular Carcinoma
    Donadon, Valter
    Balbi, Massimiliano
    Perciaccante, Antonio
    Casarin, Pietro
    Zanette, Giorgio
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2009, 2 : 25 - 33
  • [44] p53 mutation in hepatocellular carcinoma and chronic liver disease
    Ceyhan, K
    Akpolat, I
    Bozdogan, N
    Kobat, I
    Ekinci, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (07): : 1476 - 1477
  • [45] Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
    Donadon, Valter
    Balbi, Massimiliano
    Ghersetti, Michela
    Grazioli, Silvia
    Perciaccante, Antonio
    Della Valentina, Giovanni
    Gardenal, Rita
    Dal Mas, Maria
    Casarin, Pietro
    Zanette, Giorgio
    Miranda, Cesare
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (20) : 2506 - 2511
  • [46] LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma
    Kim, Young-Ah
    Park, Kwan-Kyu
    Lee, Sun-Jae
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [47] Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
    Valter Donadon
    Massimiliano Balbi
    Michela Ghersetti
    Silvia Grazioli
    Antonio Perciaccante
    Giovanni Della Valentina
    Rita Gardenal
    Maria Dal Mas
    Pietro Casarin
    Giorgio Zanette
    Cesare Miranda
    World Journal of Gastroenterology, 2009, 15 (20) : 2506 - 2511
  • [48] Can we stop the progression of chronic liver disease to hepatocellular carcinoma?
    Feitelson, Mark A.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S794 - S799
  • [49] Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma
    Ismail, Israa T.
    Elfert, Ashraf
    Helal, Marwa
    Salama, Ibrahim
    El-Said, Hala
    Fiehn, Oliver
    CANCERS, 2021, 13 (01) : 1 - 17
  • [50] Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
    Nadarevic, Tin
    Giljaca, Vanja
    Colli, Agostino
    Fraquelli, Mirella
    Casazza, Giovanni
    Miletic, Damir
    Stimac, Davor
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (10):
12345